MMP-2 suppression abrogates irradiation-induced microtubule formation in endothelial cells by inhibiting αvβ3-mediated SDF-1/CXCR4 signaling

International Journal of Oncology

Volumn 42, Issue 4, 2013, Pages 1279-1288

  Maddirela, Dilip Rajasekhar ^a   Kesanakurti, Divya ^a   Gujrati, Meena ^a   Rao, Jasti S ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

v 3 integrin; Angiogenesis; C X C chemokine receptor type 4; Immunoprecipitation; Matrix metalloprotease 2; Radiation; Stromal cell derived factor 1; Tumor conditioned media

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; ENDOTHELIAL CELL GROWTH FACTOR; GELATINASE A; PHOSPHATIDYLINOSITOL 3 KINASE; STROMAL CELL DERIVED FACTOR 1; VITRONECTIN RECEPTOR;

AIR SAC; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME INHIBITION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; MICROTUBULE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CHEMOKINE CXCL12; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE KNOCKDOWN TECHNIQUES; GLIOBLASTOMA; HUMANS; INTEGRIN ALPHAVBETA3; MATRIX METALLOPROTEINASE 2; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RADIATION TOLERANCE; RECEPTORS, CXCR4; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84874611507     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1806     Document Type: Article

References (43)

1. Ribatti D and Djonov V: Angiogenesis in development and cancer today. Int J Dev Biol 55:343-344, 2011.
2. Kargiotis O, Geka A, Rao JS and Kyritsis AP: Effects of irradiation on tumor cell survival, invasion and angiogenesis. J Neurooncol 100:323-338, 2010.
3. Wachsberger P, Burd R and Dicker AP: Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. Clin Cancer Res 9:1957-1971, 2003.
4. Chetty C, Lakka SS, Bhoopathi P, Kunigal S, Geiss R and Rao JS: Tissue inhibitor of metalloproteinase 3 suppresses tumor angiogenesis in matrix metalloproteinase 2-down-regulated lung cancer. Cancer Res 68:4736-4745, 2008.
5. Badiga AV, Chetty C, Kesanakurti D, et al: MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells. PLoS One 6:e20614, 2011.
6. Kesanakurti D, Chetty C, Bhoopathi P, Lakka SS, Gorantla B, Tsung AJ and Rao JS: Suppression of MMP-2 attenuates TNF-á induced NF-κB activation and leads to JNK mediated cell death in glioma. PLoS One 6:e19341, 2011.
7. Robinson SD and Hodivala-Dilke KM: The role of beta3-integrins in tumor angiogenesis: context is everything. Curr Opin Cell Biol 23:630-637, 2011.
8. Stupack DG, Puente XS, Boutsaboualoy S, Storgard CM and Cheresh DA: Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol 155:459-470, 2001.
9. Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G and Cheresh DA: Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157-1164, 1994.
10. Barbero S, Bonavia R, Bajetto A, et al: Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 63:1969-1974, 2003.
11. Shen XY, Wang SH, Liang ML, Wang HB, Xiao L and Wang ZH: The role and mechanism of CXCR4 and its ligand SDF-1 in the development of cervical cancer metastasis. Ai Zheng 27:1044-1049, 2008 (In Chinese).
12. Zou YR, Kottmann AH, Kuroda M, Taniuchi I and Littman DR: Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393:595-599, 1998.
13. Kucia M, Jankowski K, Reca R, et al: CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35:233-245, 2004.
14. Giannini C, Sarkaria JN, Saito A, et al: Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Neurooncology 7:164-176, 2005.
15. Kesanakurti D, Chetty C, Dinh DH, Gujrati M and Rao JS: Role of MMP-2 in the regulation of IL-6/Stat3 survival signaling via interaction with alpha5beta1 integrin in glioma. Oncogene 32:327-340, 2013.
16. Kesanakurti D, Chetty C, Maddirella DR, Gujrati M and Rao JS: Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma. Oncogene: Nov. 26, 2012 (Epub ahead of print). doi: 10.1038/onc.2012.546.
17. Chetty C, Lakka SS, Bhoopathi P and Rao JS: MMP-2 alters VEGF expression via aVB3 integrin-mediated PIK/AKT signaling in A549 lung cancer cells. Int J Cancer 127:1081-1095, 2010.
18. Kesanakurti D, Chetty C, Maddirela DR, Gujrati M and Rao JS: Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis-resistance, migration and invasion in glioma. Cell Death Dis (In Press).
19. Salvucci O, Yao L, Villalba S, Sajewicz A, Pittaluga S and Tosato G: Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 99:2703-2711, 2002.
20. Bhoopathi P, Chetty C, Gogineni VR, Gujrati M, Dinh DH, Rao JS and Lakka SS: MMP-2 mediates mesenchymal stem cell tropism towards medulloblastoma tumors. Gene Ther 18:692-701, 2011.
21. Trisciuoglio D, Iervolino A, Zupi G and Del Bufalo D: Involvement of PI3K and MAPK signaling in bcl-2-induced vascular endothelial growth factor expression in melanoma cells. Mol Biol Cell 16:4153-4162, 2005.
22. Berglin L, Sarman S, van der Plloeg I, et al: Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice. Invest Ophthalmol Vis Sci 44:403-408, 2003.
23. Abdollahi A, Griggs DW, Zieher H, et al: Inhibition of alpha (v) beta3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy. Clin Cancer Res 11:6270-6279, 2005.
24. Prise KM, Schettino G, Folkard M and Held KD: New insights on cell death from radiation exposure. Lancet Oncol 6:520-528, 2005.
25. Albert JM, Cao C, Geng L, Leavitt L, Hallahan DE and Lu B: Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models. Int J Radiat Oncol Biol Phys 65:1536-1543, 2006.
26. Monferran S, Skuli N, Delmas C, Favre G, Bonnet J, Cohen-Jonathan-Moyal E and Toulas C: Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB. Int J Cancer 123:357-364, 2008.
27. Monnier Y, Farmer P, Bieler G, et al: CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma. Cancer Res 68:7323-7331, 2008.
28. Rao JS: Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3:489-501, 2003.
29. Qian LW, Mizumoto K, Urashima T, et al: Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clin Cancer Res 8:1223-1227, 2002.
30. Trog D, Yeghiazaryan K, Fountoulakis M, et al: Pro-invasive gene regulating effect of irradiation and combined temozolomide-radiation treatment on surviving human malignant glioma cells. Eur J Pharmacol 542:8-15, 2006.
31. Speake WJ, Dean RA, Kumar A, Morris TM, Scholefield JH and Watson SA: Radiation induced MMP expression from rectal cancer is short lived but contributes to in vitro invasion. Eur J Surg Oncol 31:869-874, 2005.
32. Tseng D, Vasquez-Medrano DA and Brown JM: Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas. Br J Cancer 104:1805-1809, 2011.
33. Hanahan D and Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364, 1996.
34. Liekens S, De Clercq E and Neyts J: Angiogenesis: regulators and clinical applications. Biochem Pharmacol 61:253-270, 2001.
35. Balkwill F: The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14:171-179, 2004.
36. Chang CC, Lerman OZ, Thanik VD, et al: Dose-dependent effect of radiation on angiogenic and angiostatic CXC chemokine expression in human endothelial cells. Cytokine 48:295-302, 2009.
37. Heissig B, Rafii S, Akiyama H, et al: Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. J Exp Med 202:739-750, 2005.
38. Moeller BJ, Cao Y, Li CY and Dewhirst MW: Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals and stress granules. Cancer Cell 5:429-441, 2004.
39. Garcia-Moruja C, Alonso-Lobo JM, Rueda P, et al: Functional characterization of SDF-1 proximal promoter. J Mol Biol 348:43-62, 2005.
40. Fujimori A, Okayasu R, Ishihara H, et al: Extremely low dose ionizing radiation up-regulates CXC chemokines in normal human fibroblasts. Cancer Res 65:10159-10163, 2005.
41. Brooks PC, Clark RA and Cheresh DA: Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264:569-571, 1994.
42. Brooks PC: Role of integrins in angiogenesis. Eur J Cancer 32 A: 2423-2429, 1996.
43. Gladson CL: Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors. J Neuropathol Exp Neurol 55:1143-1149, 1996.